Ignite Creation Date:
2025-12-24 @ 2:58 PM
Ignite Modification Date:
2025-12-26 @ 8:26 AM
Study NCT ID:
NCT00632359
Status:
COMPLETED
Last Update Posted:
2020-02-10
First Post:
2008-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2015-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-03
First Submit QC Date:
None
Study First Post Date:
2008-03-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-10-26
Results First Submit QC Date:
None
Results First Post Date:
2020-02-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-29
Last Update Post Date:
2020-02-10
Last Update Post Date Type:
ACTUAL